Tech Company Financing Transactions
Molecular Templates Funding Round
On 4/13/2009, Molecular Templates received $2.5 million in funding from Sante Ventures.
Transaction Overview
Company Name
Announced On
4/13/2009
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Undisclosed
Investors
Sante Ventures (Kevin Lalande)
Proceeds Purpose
Proceeds from this financing will be used to continue product development and conduct human clinical trials.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
9301 Amberglen Blvd. 100
Austin, TX 78729
USA
Austin, TX 78729
USA
Phone
Website
Email Address
Not Recorded
Overview
Molecular Templates Inc. is creating an entirely new generation of potent anti-cancer agents based on proprietary applied proteomics technologies.The novel therapeutic agents in development by MTI are aimed particularly at melanoma, prostate and other metastatic cancers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eric Poma
Chief Financial Officer
Adam Cutler
Chief Medical Officer
Roger Waltzman
Chief Operating Officer
Jason Kim
Browse more venture capital transactions:
Prev: 4/13/2009: EndoMetabolic Solutions venture capital transaction
Next: 4/13/2009: Cooliris venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs